POLYMED Q4 FY26 Guidance vs Delivery (POLYMED Management Mirror)

Did POLYMED's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

Poly Medicure Ltd (POLYMED) Q4FY26 Management Mirror - Mar-2026 Qtr

Revenue

Management guided Mar'27 consolidated revenue between INR 2,300 crore and INR 2,400 crore, with standalone revenue between INR 1,900 crore and INR 1,950 crore representing over 15% overall growth, domestic growth upwards of 20%, and international growth above 15% as indicated in the Mar'26 Qtr. This refines the Dec'25 Qtr expectations for approximately 20% overall growth, 25% domestic growth, and 12% to 15% international growth for Mar'27, and follows the Sep'25 Qtr guidance of 15% to 16% growth for Mar'26. [Status: Initiated]

4 more themes on the ELITE plan.